CPMS | NEWSLETTER | ERN
HealthFlex
×
  • Home
  • The Network
    • Who We Are
    • Our Vision, Mission & Aim
    • Structure & Governance
    • Specialised Centres
    • Coordinators
    • Stakeholders & Supporters
    • Informative Materials
  • For Patients
    • Patient Board
    • Find a specialist centre
    • Patient Organisations
    • Patient Resources
    • Cross-border Healthcare
  • Expertise
    • Education Programme
    • Exchange Programme
    • Subnetworks
    • Work Packages
    • Transversal Activities
    • CPMS Support
    • Resources
  • News & Events
    • News
    • Events
  • Activities
    • Projects
    • Publications
    • Guidelines
    • UIMD Registry
  • Contact Us

Friends of Europe Report – Building a path for rare diseases in the European Health Data Space

Friends of Europe Report – Building a path for rare diseases in the European Health Data Space
NewsResources

Following a series of working group meetings and discussions, the Friends of Europe team drafted the report  “Building a path for rare diseases in the European Health Data Space” with the aim to set out principles, recommendations and guidelines on how legal and policy efforts at the EU level can support the digitalisation of healthcare systems, leaving no one behind.

For people living with a rare disease, it is crucial that their health data be safely connected and widely shared in order to deepen understanding, trigger medical advances, speed up the diagnostic journey and ensure that all patients – wherever they live – can benefit from the best expertise and care in Europe. The European Health Data Space (EHDS) aims to promote the reuse of health data, boost research and ensure that citizens have control over their own data.

Friends of Europe has convened a working group building on the assumption that rare disease patients are the best rationale for the EHDS. A priority for the upcoming French presidency of the Council of the European Union, the limited number of rare disease patients and the scarcity of knowledge and expertise make rare diseases a field that greatly benefits from the European joint action.

This report, describes how the needs of people living with a rare disease could be met through the proposed EHDS and, how the European Reference Networks (ERNs) with their long-term experience of data sharing within the rare diseases community can inform the governance, structure and operability of the EHDS.

Four key principles have been identified to achieve the overarching objective of optimising rare diseases data in the EHDS. The principles, recommendations and actions draw upon the ideas debated during three online working group sessions organised by Friends of Europe in 2021, as well as subsequent contributions to the debate from its participants.

Visit the Friends of Europe website and watch the event “The European Health Data Space (EHDS) – Building a path for rare diseases and learning from its experience”

Read the full report

Search

Last News & Events

  • Recordati Rare Diseases – Training courses on inherited metabolic diseases
  • Rare paediatric neurological diseases: A focus on Europe – Report by the Economist Impact
  • Rare Liver Diseases in Europe – Recent Webinar by GLI
  • New COVID-19 publication: infection rates and symptoms in IMD patients
  • #ERNcare4UA – A dedicated website to help health professionals find support for Ukrainian patients
  • Newborn screening – read the new publication
  • In solidarity with Ukraine and Ukrainian rare metabolic disease patients
  • EJP RD WORKSHOP – Endocrine cancer: A challenge in adults and children

Activities

  • Publications and Guidelines
  • Unified Registry for Inherited Metabolic Disorders
  • Projects

Disclaimer

MetabERN is a European Reference Network (ERN) approved by the ERN Board of Member States.
The ERNs are co-funded by the European Commission.
For more information about the ERNs and the EU health strategy, please visit ec.europa.eu/health/ern
The content on this website represents the views of the network and is its sole responsibility; it can in no way be taken to reflect the views of the European Commission or any other body of the European Union.

For more information please contact
Prof. Maurizio Scarpa, MD, PhD
MetabERN Coordinator

Newsletter

Follow us on Twitter

Tweets by @Metab_ERN

Search the website


Copyright ©2017-2021 all rights reserved
Previous Content

Web by EFFIGE 2.0
To provide the best possible service, we use technical, statistical and third-party cookies on this site. Continuing the navigation you consent to use them. Accept Reject Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT